BioVersys
Series BBasel, SwitzerlandSep 2020
BioVersys raised €18M in a Series B round in Sep 2020. The company is based in Basel, Switzerland. Data as of Nov 2026.
Amount raised
€18M
€17,635,047
Native amount
19,000,000 CHF
Stage
Series B
series b
Investors
0
Provenance & confidence
High confidenceAmount
19,000,000 CHF
ECB-at-date → €18M · rate 1.0774 on 2020-08-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Sep 2020
Round type
series b
Amount (EUR)
€18M